Literature DB >> 27919805

UPLC-MS for metabolomics: a giant step forward in support of pharmaceutical research.

Ala F Nassar1, Terence Wu2, Samuel F Nassar3, Adam V Wisnewski4.   

Abstract

Metabolomics is a relatively new and rapidly growing area of post-genomic biological research. As use of metabolomics technology grows throughout the spectrum of drug discovery and development, and its applications broaden, its impact is expanding dramatically. This review seeks to provide the reader with a brief history of the development of metabolomics, its significance and strategies for conducting metabolomics studies. The most widely used analytical tools for metabolomics: NMR, LC-MS and GC-MS, are discussed along with considerations for their use. Herein, we will show how metabolomics can assist in pharmaceutical research studies, such as pharmacology and toxicology, and discuss some examples of the importance of metabolomics analysis in research and development.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27919805      PMCID: PMC5721520          DOI: 10.1016/j.drudis.2016.11.020

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  51 in total

Review 1.  Metabolomics: a global biochemical approach to drug response and disease.

Authors:  Rima Kaddurah-Daouk; Bruce S Kristal; Richard M Weinshilboum
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 2.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

Review 3.  Metabolomics: Applications and Promise in Mycobacterial Disease.

Authors:  Mehdi Mirsaeidi; Mohammad Mehdi Banoei; Brent W Winston; Dean E Schraufnagel
Journal:  Ann Am Thorac Soc       Date:  2015-09

Review 4.  Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.

Authors:  Aurélie Morin; Eric Letouzé; Anne-Paule Gimenez-Roqueplo; Judith Favier
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

5.  The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical Path.

Authors:  Federico M Goodsaid; Felix W Frueh; William Mattes
Journal:  Drug Discov Today Technol       Date:  2007

Review 6.  Emerging applications of metabolomics in drug discovery and precision medicine.

Authors:  David S Wishart
Journal:  Nat Rev Drug Discov       Date:  2016-03-11       Impact factor: 84.694

7.  In search of secreted protein biomarkers for the anti-inflammatory effect of beta2-adrenergic receptor agonists: application of DIGE technology in combination with multivariate and univariate data analysis tools.

Authors:  Kitty C M Verhoeckx; Marco Gaspari; Sabina Bijlsma; Jan van der Greef; Renger F Witkamp; Robert P Doornbos; Richard J T Rodenburg
Journal:  J Proteome Res       Date:  2005 Nov-Dec       Impact factor: 4.466

Review 8.  Improving the decision-making process in structural modification of drug candidates: reducing toxicity.

Authors:  Alaa-Eldin F Nassar; Amin M Kamel; Caroline Clarimont
Journal:  Drug Discov Today       Date:  2004-12-15       Impact factor: 7.851

9.  Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge.

Authors:  Joo-Youn Cho; Tsutomu Matsubara; Dong Wook Kang; Sung-Hoon Ahn; Kristopher W Krausz; Jeffrey R Idle; Hans Luecke; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2009-11-09       Impact factor: 5.922

10.  Isocyanate vapor-induced antigenicity of human albumin.

Authors:  Adam V Wisnewski; Meredith H Stowe; André Cartier; Qing Liu; Jian Liu; Liang Chen; Carrie A Redlich
Journal:  J Allergy Clin Immunol       Date:  2004-06       Impact factor: 10.793

View more
  15 in total

1.  Metabolomic Analysis Reveals that SPHK1 Promotes Oral Squamous Cell Carcinoma Progression through NF-κB Activation.

Authors:  Chen-Xing Hou; Guang-Yan Mao; Qiu-Wangyue Sun; Ying Meng; Qing-Hai Zhu; Yu-Ting Tang; Wei Han; Nan-Nan Sun; Xiao-Meng Song; Chen-Xing Wang; Jin-Hai Ye
Journal:  Ann Surg Oncol       Date:  2022-07-12       Impact factor: 4.339

2.  Subchronic Graphene Exposure Reshapes Skin Cell Metabolism.

Authors:  Javier Frontiñan-Rubio; Emilio Llanos-González; Viviana Jehová González; Ester Vázquez; Mario Durán-Prado
Journal:  J Proteome Res       Date:  2022-05-25       Impact factor: 5.370

3.  Metabolomics: a promising diagnostic and therapeutic implement for breast cancer.

Authors:  Zhanghan Chen; Zehuan Li; Haoran Li; Ying Jiang
Journal:  Onco Targets Ther       Date:  2019-08-21       Impact factor: 4.147

4.  Alterations of Gut Microbiome and Metabolite Profiling in Mice Infected by Schistosoma japonicum.

Authors:  Yue Hu; Jiansong Chen; Yiyue Xu; Hongli Zhou; Ping Huang; Yubin Ma; Minzhao Gao; Shaoyun Cheng; Haiyun Zhou; Zhiyue Lv
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

Review 5.  Application of Metabolomics in Alzheimer's Disease.

Authors:  Jordan Maximillian Wilkins; Eugenia Trushina
Journal:  Front Neurol       Date:  2018-01-12       Impact factor: 4.003

6.  Concentration of Lactoferrin in Human Milk and Its Variation during Lactation in Different Chinese Populations.

Authors:  Zhenyu Yang; Rulan Jiang; Qi Chen; Jie Wang; Yifan Duan; Xuehong Pang; Shan Jiang; Ye Bi; Huanmei Zhang; Bo Lönnerdal; Jianqiang Lai; Shian Yin
Journal:  Nutrients       Date:  2018-09-05       Impact factor: 5.717

7.  UPLC Quantitative Analysis of Multi-Components by Single Marker and Quality Evaluation of Polygala tenuifolia Wild. Extracts.

Authors:  Rui Xu; Fuying Mao; Yunsheng Zhao; Wenping Wang; Lingling Fan; Xiaojuan Gao; Jianjun Zhao; Hongling Tian
Journal:  Molecules       Date:  2017-12-20       Impact factor: 4.411

8.  The metabolomic quest for a biomarker in chronic kidney disease.

Authors:  Robert Davies
Journal:  Clin Kidney J       Date:  2018-06-02

Review 9.  Precision Medicine: Steps along the Road to Combat Human Cancer.

Authors:  Samuel F Nassar; Khadir Raddassi; Baljit Ubhi; Joseph Doktorski; Ahmad Abulaban
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

Review 10.  Metabolomic Laboratory-Developed Tests: Current Status and Perspectives.

Authors:  Steven Lichtenberg; Oxana P Trifonova; Dmitry L Maslov; Elena E Balashova; Petr G Lokhov
Journal:  Metabolites       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.